First oral norovirus vaccine tested in moms to protect babies
NCT ID NCT07254728
Summary
This study tested a new oral vaccine designed to protect against norovirus, a common cause of stomach flu. It involved 76 healthy, breastfeeding women who received either the vaccine or a placebo. The main goals were to check the vaccine's safety and to see if protective antibodies produced by the mother could be passed to her baby through breastmilk.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NOROVIRUS INFECTIONS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
FCRN Clinical Trials Centre (Pty) Ltd
Vereeniging, 1935, South Africa
-
Newtown Clinical Research Centre
Johannesburg, 2001, South Africa
-
Progress Clinical Research Unit
Honeydew, 2040, South Africa
-
Trident Clinical
Kimberley, 8301, South Africa
-
WITS RHI Research Centre
Hillbrow, 2001, South Africa
Conditions
Explore the condition pages connected to this study.